Compared with traditional antibodies (about 150 kDa), small binding agents (such as antibody mimetics, affibodies, or designed ankyrin repeat proteins) typically have molecular weights of only a few to a dozen-plus kDa, offering better tissue penetration and lower manufacturing costs.